Getting Up to Speed on the Evolving Landscape of Multiple Sclerosis: Annette Okai, MD
The medical director of the North Texas Institute of Neurology and Headache offered an overview of the State of the Science Summit that was held on July 21, 2022, with a variety of expert clinicians in MS care. [WATCH TIME: 3 minutes]
WATCH TIME: 3 minutes
NeurologyLive® State of the Science events are short meetings designed to educate neurologists and APPs on the clinical benefits associated with the new science driving new thinking. Our renowned faculty focuses on the most relevant topics to ultimately improve patient care.
In this recent event, held on July 21, 2022, a panel of experts in the care of multiple sclerosis (MS) convened to discuss the drastic evolution of MS therapeutic approaches in the past 30 years, as well as to detail some of the latest entrants into the treatment toolbox. This conversation included overviews of the recent oral medications and B cell depleters, and a look into what investigational treatments are on the horizon for the field.
TOPICS INCLUDE:
- The Evolving Landscape of Multiple Sclerosis - Mechanisms of Action and Targets of Treatment — Fernando Cuascut, MD, MPH
- FDA Approved Oral Medications for MS — Lauren Tardo, MD
- FDA Approved B Cell Depleting Medications for MS — Rebecca Romero, MD
- Emerging Treatments for MS — Annette Okai, MD
Click the button below to watch the recent State of the Science Summit with Okai et al.
